GI Dynamics to participate in 2010 Medical Innovation Summit

GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced that Stuart A. Randle, chief executive officer, will participate in a panel discussion as part of the 2010 Medical Innovation Summit being held at the Cleveland Clinic November 1-3, 2010 in Cleveland, Ohio. The focus of this year's summit, obesity, diabetes and the metabolic crisis, will bring together international leaders and researchers in healthcare to share their perspectives and discuss innovations in the way these diseases may be prevented, managed and treated.

“The Revolution in Diabetes Treatment, Surgical Intervention & Novel Therapies Explored”

"Forums like the Medical Innovation Summit provide an opportunity to engage, educate and learn about existing best practices and new treatment approaches that will help improve and manage these twin epidemics, and shape the future of patient care," said Mr. Randle. "I am pleased to be part of this forum, and appreciate the opportunity to contribute our thinking and insights gleaned from our efforts to develop the EndoBarrier, a non-surgical therapeutic for the treatment of type 2 diabetes and obesity."

Mr. Randle will participate in a panel, "The Revolution in Diabetes Treatment, Surgical Intervention & Novel Therapies Explored," on November 3, 2010 at 9:10 a.m. (EDT). Panelists will discuss forthcoming diabetes disease management and therapeutic treatment options, including GI Dynamics' EndoBarrier Gastrointestinal Liner.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI-based video system may offer quick, no-contact screenings for high blood pressure and diabetes